NEW YORK (
) hit a new 52-week high Friday as it is currently trading at $74.78, above its previous 52-week high of $74.75 with 89,432 shares traded as of 3:40 p.m. ET. Average volume has been 336,400 shares over the past 30 days.
Zoll Medical has a market cap of $1.49 billion and is part of the
industry. Shares are up 17.2% year to date as of the close of trading on Thursday.
ZOLL Medical Corporation develops, manufactures, and markets resuscitation devices, related data management and software solutions, and temperature management technology worldwide. The company has a P/E ratio of 53, below the average health services industry P/E ratio of 68.5 and above the S&P 500 P/E ratio of 17.7.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter
TheStreet Ratings rates Zoll Medical as a
. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. You can view the full
52-week high stocks
or get investment ideas from our